SkyePharma Thoughts Turn To M&A And In-House Research After Financial Turnaround
This article was originally published in Scrip
Executive Summary
With increasing revenues and profits the UK drug delivery firm SkyePharma could only dream of some years ago, CEO Peter Grant says he will consider investing in internal research and external M&A opportunities, in a measured way, to build a long-term product pipeline.